TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Acumen Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 12, 2025

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Acumen Pharmaceuticals
Acumen Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 12, 2025

Acumen Pharmaceuticals will report its Q3 2025 financial results on November 12, 2025, hosting a conference call and webcast to provide a business and financial update. The company is developing a novel therapeutic targeting toxic amyloid beta oligomers for Alzheimer's disease treatment.

Insights
ABOS   neutral

Standard financial reporting announcement with ongoing clinical development of Alzheimer's therapeutic, indicating steady progress without significant positive or negative indicators